SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-16-155145
Filing Date
2016-11-07
Accepted
2016-11-07 14:47:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9693
  Complete submission text file 0001104659-16-155145.txt   10540
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations